Advances in the management of idiopathic pulmonary fibrosis

Jay H Ryu, Craig E. Daniels

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Idiopathic pulmonary fibrosis (IPF) is a common form of interstitial lung disease and usually results in progressive respiratory insufficiency and death. Steady progress has been made in understanding the pathogenesis of IPF and multiple clinical trials are ongoing, but effective therapy remains elusive.

Original languageEnglish (US)
Article number28
JournalF1000 Medicine Reports
Volume2
Issue number1
DOIs
StatePublished - Apr 12 2010

Fingerprint

Idiopathic Pulmonary Fibrosis
Interstitial Lung Diseases
Respiratory Insufficiency
Clinical Trials
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Advances in the management of idiopathic pulmonary fibrosis. / Ryu, Jay H; Daniels, Craig E.

In: F1000 Medicine Reports, Vol. 2, No. 1, 28, 12.04.2010.

Research output: Contribution to journalArticle

@article{bd99005ec72a4658b9ad55930bff3d21,
title = "Advances in the management of idiopathic pulmonary fibrosis",
abstract = "Idiopathic pulmonary fibrosis (IPF) is a common form of interstitial lung disease and usually results in progressive respiratory insufficiency and death. Steady progress has been made in understanding the pathogenesis of IPF and multiple clinical trials are ongoing, but effective therapy remains elusive.",
author = "Ryu, {Jay H} and Daniels, {Craig E.}",
year = "2010",
month = "4",
day = "12",
doi = "10.3410/M2-28",
language = "English (US)",
volume = "2",
journal = "F1000 Medicine Reports",
issn = "1757-5931",
publisher = "Medicine Reports Limited",
number = "1",

}

TY - JOUR

T1 - Advances in the management of idiopathic pulmonary fibrosis

AU - Ryu, Jay H

AU - Daniels, Craig E.

PY - 2010/4/12

Y1 - 2010/4/12

N2 - Idiopathic pulmonary fibrosis (IPF) is a common form of interstitial lung disease and usually results in progressive respiratory insufficiency and death. Steady progress has been made in understanding the pathogenesis of IPF and multiple clinical trials are ongoing, but effective therapy remains elusive.

AB - Idiopathic pulmonary fibrosis (IPF) is a common form of interstitial lung disease and usually results in progressive respiratory insufficiency and death. Steady progress has been made in understanding the pathogenesis of IPF and multiple clinical trials are ongoing, but effective therapy remains elusive.

UR - http://www.scopus.com/inward/record.url?scp=77955061939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955061939&partnerID=8YFLogxK

U2 - 10.3410/M2-28

DO - 10.3410/M2-28

M3 - Article

VL - 2

JO - F1000 Medicine Reports

JF - F1000 Medicine Reports

SN - 1757-5931

IS - 1

M1 - 28

ER -